CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Calendar Charles River Laboratories International, Inc.

Equities

CRL

US1598641074

Biotechnology & Medical Research

Market Closed - Nyse Other stock markets 21:00:02 21/05/2025 BST			5-day change	1st Jan Change
134.98 ^USD	-5.96%		-6.28%	-26.88%

05-14	Charles River Laboratories International, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 08:40 AM
05-14	TD Cowen Upgrades Charles River Laboratories International to Buy From Hold, Adjusts PT to $179 From $105	MT

Chart calendar Charles River Laboratories International, Inc.

dd3519bc4f487c8021a.Et6CKTdkGixI7IfCblUinQkSHjbRGMxBoC03qHU4Iho.YYbxRWMzckgBubfyLw1GpWhKblGYbKdx5WxE_RtrTlxlmNFaZAFWFS-K4A~85cab5d39f91bd9615076d9a8e508fb3

Upcoming events on Charles River Laboratories International, Inc.

29/07/2025	Q2 2025 Earnings Release (Projected)
28/10/2025	Q3 2025 Earnings Release (Projected)
17/02/2026	Q4 2025 Earnings Release (Projected)
06/05/2026	Q1 2026 Earnings Release (Projected)

Past events on Charles River Laboratories International, Inc.

20/05/2025 13:00	Annual General Meeting
14/05/2025 16:40	Bank of America Global Healthcare Conference
07/05/2025 14:00	Q1 2025 Earnings Call
07/05/2025 12:00	Q1 2025 Earnings Release
12/03/2025 13:30	Barclays Global Healthcare Conference
19/02/2025 13:30	Q4 2024 Earnings Call
19/02/2025 12:00	Q4 2024 Earnings Release
14/01/2025 22:15	JP Morgan Healthcare Conference
04/12/2024 15:00	Evercore ISI HealthCONx Conference
20/11/2024 14:00	Jefferies London Healthcare Conference
12/11/2024 18:15	UBS Global Healthcare Conference
06/11/2024 14:30	Q3 2024 Earnings Call
06/11/2024 12:00	Q3 2024 Earnings Release
04/10/2024	Society for Neuroscience Conference
10/09/2024 15:15	Baird Global Healthcare Conference
05/09/2024 14:15	Morgan Stanley Healthcare Conference
07/08/2024 14:00	Q2 2024 Earnings Call
07/08/2024 12:00	Q2 2024 Earnings Release
05/06/2024 15:00	Jefferies Global Healthcare Conference
04/06/2024 16:00	William Blair Growth Stock Conference

Annual results

Fiscal Period	December	2022	2023	2024	2025	2026	2027
Net sales Million USD	Released Forecast Spread	3 976 3 915 1.56%	4 129 4 107 0.54%	4 050 4 031 0.47%	3 883	3 963	4 084
EBITDA Million USD	Released Forecast Spread	991 982 0.87%	1 013 1 017 -0.4%	996 998 -0.19%	947	980	1 049
EBIT Million USD	Released Forecast Spread	834 820 1.67%	839 842 -0.35%	806 802 0.46%	752	793	846
Earnings before Tax (EBT) Million USD	Released Forecast Spread	623 568 9.63%	581 513 13.41%	93,1 401 -76.8%	336	381	420
Net income Million USD	Released Forecast Spread	486 409 18.85%	475 387 22.66%	10,3 301 -96.58%	222	286	329
EPS USD	Released Forecast Spread	9,48 7,97 18.98%	9,22 7,49 23.07%	0,20 5,83 -96.57%	4,53	5,89	6,91
Announcement Date		22/02/23	14/02/24	19/02/25	-

Quarterly results

Fiscal Period	March	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1
Net sales Million USD	Released Forecast Spread	1 027 1 000 2.61%	1 013 991 2.24%	1 012 993 1.82%	1 026 1 024 0.18%	1 010 975 3.51%	1 003 984 1.92%	984 942 4.48%	984	960	964	994	999	983	992	1 029
EBITDA Million USD	Released Forecast Spread	255 241 5.8%	239 242 -1.38%	233 222 4.94%	266 243 9.71%	249 241 3.11%	248 245 1.35%	386 217 78.05%	240	235	236	243	244	241	245	256
EBIT Million USD	Released Forecast Spread	211 194 8.51%	194 196 -1%	187 178 5.43%	219 196 11.62%	200 190 5.51%	200 196 1.71%	188 169 11.54%	194	184	185	194	199	194	192	203
Earnings before Tax (EBT) Million USD	Released Forecast Spread	113 120 -6.11%	209 120 74.62%	99,0 96,3 2.82%	120 111 7.99%	91,2 87,9 3.79%	-217 66,0 -428.29%
Net income Million USD	Released Forecast Spread	87,4 88,9 -1.74%	187 92,4 102.53%	67,3 71,2 -5.45%	90,0 83,9 7.32%	68,7 78,2 -12.16%	-216 47,5 -553.65%	25,5 45,3 -43.75%	52,6	53,9	56,9	59,8	59,7	75,8	76,0	84,3
EPS USD	Released Forecast Spread	1,69 1,68 0.51%	3,62 1,78 103.94%	1,30 1,35 -3.7%	1,74 1,68 3.88%	1,33 1,56 -14.88%	-4,22 1,19 -453.88%	0,50 0,97 -48.45%	1,28	1,38	1,40	1,52	1,61	1,76	1,77	1,73
Announcement Date		08/11/23	14/02/24	09/05/24	07/08/24	06/11/24	19/02/25	07/05/25	-	-	-	-	-	-	-	-

Upcoming sector events for Charles River Laboratories International, Inc.

27/05/2025	MESOBLAST LIMITED: Q3 2025 Earnings Release (Projected)
27/05/2025	IMMUNOVANT, INC.: Q4 2025 Earnings Release (Projected)
22/07/2025	ALKERMES PLC: Q2 2025 Earnings Release (Projected)
22/07/2025	ICON PUBLIC LIMITED COMPANY: Q2 2025 Earnings Release (Projected)
22/07/2025	SYNGENE INTERNATIONAL LIMITED: Q1 2026 Earnings Release (Projected)
22/07/2025	LONZA GROUP AG: Q2 2025 Earnings Release
23/07/2025 21:01	GALAPAGOS NV: Q2 2025 Earnings Release
23/07/2025	EUROFINS SCIENTIFIC SE: Q2 2025 Earnings Release
24/07/2025 06:00	BACHEM HOLDING AG: Q2 2025 Earnings Release
24/07/2025	PHARVARIS N.V.: Q2 2025 Earnings Release (Projected)

More events

Past sector events for Charles River Laboratories International, Inc.

Today	REPLIMUNE GROUP, INC.: Q4 2025 Earnings Release
21/05/2025 07:00	BIOARCTIC AB: Q1 2025 Earnings Release
20/05/2025	EXSCIENTIA PLC: Q1 2025 Earnings Release (Projected)
20/05/2025 12:00	CUREVAC N.V.: Q1 2025 Earnings Release
14/05/2025	GI INNOVATION, INC.: Q1 2025 Earnings Release
14/05/2025	GNI GROUP LTD.: Q1 2025 Earnings Release
14/05/2025 21:32	SS INNOVATIONS INTERNATIONAL, INC.: Q1 2025 Earnings Release
14/05/2025 12:30	ARBUTUS BIOPHARMA CORPORATION: Q1 2025 Earnings Release
14/05/2025 12:00	CENTESSA PHARMACEUTICALS PLC: Q1 2025 Earnings Release
14/05/2025 12:00	ARS PHARMACEUTICALS, INC.: Q1 2025 Earnings Release